Pub. Date : 2004 Mar-Apr
PMID : 15086213
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis. | Octreotide | interleukin 6 | Homo sapiens |
| 2 | Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis. | Octreotide | interleukin 6 | Homo sapiens |
| 3 | BACKGROUND/AIMS: Based on former studies in experimental animals on the effect of octreotide on serum and ascitic levels of tumor necrosis factor-alpha and interleukin-6 in the field of necrotizing pancreatitis, the present study was designed to investigate the effect of octreotide on serum interleukin-6 of patients with acute edematous pancreatitis. | Octreotide | interleukin 6 | Homo sapiens |
| 4 | BACKGROUND/AIMS: Based on former studies in experimental animals on the effect of octreotide on serum and ascitic levels of tumor necrosis factor-alpha and interleukin-6 in the field of necrotizing pancreatitis, the present study was designed to investigate the effect of octreotide on serum interleukin-6 of patients with acute edematous pancreatitis. | Octreotide | interleukin 6 | Homo sapiens |
| 5 | RESULTS: Mean concentrations of interleukin-6 of patients treated with octreotide 200 microg tid were 59.52 pg/mL before and 94.08, 46.25, 49.94, 58.16 and 26.08 pg/mL at 3, 6, 24, 48 and 72 hours after the start of therapy respectively. | Octreotide | interleukin 6 | Homo sapiens |
| 6 | CONCLUSIONS: A transient, but not statistically significant, decrease of serum interleukin-6 levels was documented after administration of octreotide in the field of acute edematous pancreatitis. | Octreotide | interleukin 6 | Homo sapiens |